Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Conditions: Pulmonary Carcinoid Tumor; Recurrent Gastrointestinal Carcinoid Tumor; Recurrent Renal Cell Cancer; Recurrent Uterine Sarcoma; Stage III Renal Cell Cancer; Stage IIIB Uterine Sarcoma; Stage IIIC Uterine Sarcoma; Stage IV Renal Cell Cancer; Stage IVA Uterine Sarcoma; Stage IVB Uterine Sarcoma; Unspecified Adult Solid Tumor, Protocol SpecificInterventions: Biological: trebananib; Drug: temsirolimus; Other: pharmacological study; Other: laboratory biomarker analysisSponsor: National Cancer Institute (NCI)Active, not rec...
Source: ClinicalTrials.gov - February 24, 2012 Category: Research Source Type: clinical trials
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
Conditions: Stage I Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Drug: doxorubicin hydrochloride; Drug: gemcitabine hydrochloride; Drug: docetaxel; Biological: filgrastim; Biological: pegfilgrastim; Other: clinical observationSponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)Recruiting - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2012 Category: Research Source Type: clinical trials
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
Conditions: Stage I Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Drug: doxorubicin hydrochloride; Drug: gemcitabine hydrochloride; Drug: docetaxel; Biological: filgrastim; Biological: pegfilgrastim; Other: clinical observationSponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)Recruiting - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2012 Category: Research Source Type: clinical trials
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
Conditions: Stage I Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Drug: doxorubicin hydrochloride; Drug: gemcitabine hydrochloride; Drug: docetaxel; Biological: filgrastim; Biological: pegfilgrastim; Other: clinical observationSponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)Recruiting - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2012 Category: Research Source Type: clinical trials
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
Conditions: Stage I Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Drug: doxorubicin hydrochloride; Drug: gemcitabine hydrochloride; Drug: docetaxel; Biological: filgrastim; Biological: pegfilgrastim; Other: clinical observationSponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)Recruiting - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2012 Category: Research Source Type: clinical trials
